$227 Million is the total value of Integral Health Asset Management, LLC's 51 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.27% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -60,000 | -100.0% | -0.36% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -0.42% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -20,000 | -100.0% | -0.53% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -30,000 | -100.0% | -0.61% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.63% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -75,000 | -100.0% | -0.63% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.65% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -10,000 | -100.0% | -0.80% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -25,000 | -100.0% | -0.85% | – |
| MYL | Exit | MYLAN N V | $0 | – | -130,000 | -100.0% | -1.02% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -75,000 | -100.0% | -1.11% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -65,000 | -100.0% | -1.15% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -100,000 | -100.0% | -1.16% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -35,000 | -100.0% | -1.20% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -30,000 | -100.0% | -1.34% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -175,000 | -100.0% | -1.46% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -55,000 | -100.0% | -1.54% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -90,000 | -100.0% | -1.54% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -70,000 | -100.0% | -2.13% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -80,000 | -100.0% | -2.41% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -50,000 | -100.0% | -2.56% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -100,000 | -100.0% | -2.89% | – |
| TFX | Exit | TELEFLEX INC | $0 | – | -21,000 | -100.0% | -3.08% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -95,000 | -100.0% | -3.28% | – |
| VAR | Exit | VARIAN MED SYS INC | $0 | – | -60,000 | -100.0% | -3.32% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -190,000 | -100.0% | -3.71% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -65,000 | -100.0% | -4.22% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -60,000 | -100.0% | -5.11% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -170,000 | -100.0% | -5.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.